This brand name is authorized in Nigeria.
The drug NOSCLAV contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
544Y3D6MYH - AMOXICILLIN SODIUM
|
|
Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death. |
|
2
|
UNII
Q42OMW3AT8 - CLAVULANATE POTASSIUM
|
|
Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-1740 | Tablet | Nosclav-625 Tablets TAB 500 mg; 125 mg | Each tablet contains: Amoxicillin Trihydrate equiv. to Amoxicillin 500 mg, Clavulanate Potassium equiv. to Clavulanic Acid 125 mg | 21/12/2020 |
| A4-1875 | Tablet | Nosclav-375 Tablets TAB 250 mg; 125 mg | Each tablet contains: Amoxicillin Trihydrate equiv. to Amoxicillin 250 mg, Clavulanate Potassium equiv. to Clavulanic Acid 125 mg | 21/12/2020 |
| A4-7680 | Powder for suspension | NOSCLAV-228.5 POWDER FOR ORAL SUSPENSION PWD_F_SOL 200 mg; 28.5 mg 1 X 100ML | 36 RNW-PP-273447 NOSCLAV-228.5 POWDER FOR ORAL SUSPENSION AMOXICILLIN TRIHYDRATE+ CLAVULANATE ACID AMOXICILLIN TRIHYDRATE EQV. TO AMOXICILLIN 200MG + POTASSIUM CLAVULANATE EQV. TO CLAVULANIC ACID 28.5MG/5ML A4-7680 Drugs Imported Products 1X100ML POM 2 9/20/2022 GENEITH PHARMACEUTICALS LIMITED, ADEWALE CRESCENT, OFF EWENLA STREET, OSHODI ISOLO LAGOS 8122912281 ngouzoamaka@yahoo.com FINECURE PHARMACEUTICALS LIMITED, VILL SHIMLA PISTAUR, MALSA ROAD, KICHHA, UDHAMSINGH NAGAR, UTTARAKHAND- 263148, INDIA. , India | 27/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01CR02 | Amoxicillin and enzyme inhibitor | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-1740, A4-1875, A4-7680, B4-8110 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.